These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10121083)

  • 1. Can (should) states enact antitrust immunity for health care providers?
    Weissburg C; Enders RJ
    Health Syst Rev; 1992; 25(5):47-9. PubMed ID: 10121083
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinton administration's new antitrust guidelines duck many important issues.
    Sneed JH; Marx D
    Healthspan; 1993 Nov; 10(10):25-9. PubMed ID: 10130837
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitrust enforcement guidelines for providers in the wake of health care reform.
    Zoric S
    J Health Hosp Law; 1993 Dec; 26(12):359-64, 358. PubMed ID: 10138597
    [No Abstract]   [Full Text] [Related]  

  • 4. A practical guide to health care antitrust issues.
    Kopit WG; Barnes CE; Latorre L
    Trustee; 1986 May; 39(5):16-8. PubMed ID: 10276551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care collaboration, antitrust, and the 1992 merger guidelines: do competition and cost effective co-operation conflict?
    Adler H
    J Health Hosp Law; 1992 Jul; 25(7):193-200. PubMed ID: 10123591
    [No Abstract]   [Full Text] [Related]  

  • 6. Avoiding antitrust compliance difficulties in mergers and acquisitions.
    Bryant LE
    Healthc Financ Manage; 1993 Aug; 47(8):48-50, 52, 54-8. PubMed ID: 10145853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care antitrust guidelines clarify enforcement policy.
    Enders RJ
    Health Care Law Newsl; 1993 Dec; 8(12):3-8. PubMed ID: 10130818
    [No Abstract]   [Full Text] [Related]  

  • 8. Insights for hospitals: the 1994 health care antitrust enforcement policy statements.
    Marx D; Busey RC
    J Health Hosp Law; 1995; 28(3):143-50. PubMed ID: 10155907
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitrust: stage 1 of health reform.
    Leech JD
    Trustee; 1993 Dec; 46(12):16-7. PubMed ID: 10130690
    [No Abstract]   [Full Text] [Related]  

  • 10. Minimizing antitrust exposure in a virtual merger.
    Brock TH
    Healthc Financ Manage; 1999 Sep; 53(9):38-44. PubMed ID: 11066705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitrust law in 1995: mixed messages for providers.
    Enders RJ
    Health Syst Rev; 1996; 29(2):39-40, 44, 46-7. PubMed ID: 10156518
    [No Abstract]   [Full Text] [Related]  

  • 12. Special report: Antitrust and health care. Anticipating antitrust pitfalls in new health care ventures.
    Brett BJ; Porter KD; Rinehart SG
    Benders Health Care Law Mon; 1996 Feb; ():3-12. PubMed ID: 10158210
    [No Abstract]   [Full Text] [Related]  

  • 13. Not so fast. Doctors and hospitals are running head-on into federal antitrust laws.
    Serafini MW
    Natl J (Wash); 1994 Dec; 26(51-52):2967-70. PubMed ID: 10139127
    [No Abstract]   [Full Text] [Related]  

  • 14. Additional antitrust guidance announced.
    Roeder KH
    Ga Hosp Today; 1994 Oct; 38(10):3. PubMed ID: 10143370
    [No Abstract]   [Full Text] [Related]  

  • 15. The developing application of antitrust laws to hospital mergers.
    Mudge OS; Gibofsky A
    J Leg Med; 1994 Sep; 15(3):355-84. PubMed ID: 7964156
    [No Abstract]   [Full Text] [Related]  

  • 16. Antitrust rules eased, but is there an issue?
    Burda D
    Mod Healthc; 1994 Oct; 24(40):4. PubMed ID: 10137213
    [No Abstract]   [Full Text] [Related]  

  • 17. Antitrust developments in healthcare: emphasis on net effects rather than structural presumptions.
    Ewing KP; Koslov TI
    Benders Health Care Law Mon; 1996 Mar; ():3-12. PubMed ID: 10158209
    [No Abstract]   [Full Text] [Related]  

  • 18. The new antitrust "safe-harbors".
    Craft JA
    Integr Healthc Rep; 1993 Nov; ():11-3. PubMed ID: 10131005
    [No Abstract]   [Full Text] [Related]  

  • 19. Perspectives. Antitrust enforcement: reshaping the health system.
    Kent C
    Faulkner Grays Med Health; 1994 Dec; 48(48):suppl 1-4. PubMed ID: 10138740
    [No Abstract]   [Full Text] [Related]  

  • 20. Reading the antitrust road map.
    Kaplan GL
    Provider; 1995 May; 21(5):89-90, 92. PubMed ID: 10142403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.